BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25082753)

  • 1. Combination of doxorubicin-based chemotherapy and polyethylenimine/p53 gene therapy for the treatment of lung cancer using porous PLGA microparticles.
    Shi X; Li C; Gao S; Zhang L; Han H; Zhang J; Shi W; Li Q
    Colloids Surf B Biointerfaces; 2014 Oct; 122():498-504. PubMed ID: 25082753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
    Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
    Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer.
    Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
    Biomaterials; 2012 Aug; 33(22):5574-83. PubMed ID: 22579235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer.
    Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
    Biomaterials; 2013 Sep; 34(27):6444-53. PubMed ID: 23755831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the Intracellular Drug Concentration in Lung Cancer Treatment through the Codelivery of Doxorubicin and miR-519c Mediated by Porous PLGA Microparticle.
    Wu D; Wang C; Yang J; Wang H; Han H; Zhang A; Yang Y; Li Q
    Mol Pharm; 2016 Nov; 13(11):3925-3933. PubMed ID: 27684197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
    Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
    J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment.
    Feng T; Tian H; Xu C; Lin L; Xie Z; Lam MH; Liang H; Chen X
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1086-93. PubMed ID: 25305583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
    Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
    J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.
    Dhanda DS; Tyagi P; Mirvish SS; Kompella UB
    J Control Release; 2013 Jun; 168(3):239-50. PubMed ID: 23562638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor.
    Choi JW; Park JH; Baek SY; Kim DD; Kim HC; Cho HJ
    Colloids Surf B Biointerfaces; 2015 Aug; 132():305-12. PubMed ID: 26057730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monodisperse double-walled microspheres loaded with chitosan-p53 nanoparticles and doxorubicin for combined gene therapy and chemotherapy.
    Xu Q; Xia Y; Wang CH; Pack DW
    J Control Release; 2012 Oct; 163(2):130-5. PubMed ID: 22981564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery.
    Cocks E; Alpar O; Somavarapu S; Greenleaf D
    Drug Dev Ind Pharm; 2015 Mar; 41(3):522-8. PubMed ID: 24650006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable functional mixed-polymer microspheres to enhance doxorubicin release behavior for lung cancer treatment.
    Li W; Chen S; Zhang L; Zhang Y; Yang X; Xie B; Guo J; He Y; Wang C
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111350. PubMed ID: 32911292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan.
    Jiang T; Singh B; Li HS; Kim YK; Kang SK; Nah JW; Choi YJ; Cho CS
    Biomaterials; 2014 Feb; 35(7):2365-73. PubMed ID: 24342722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas-generating TPGS-PLGA microspheres loaded with nanoparticles (NIMPS) for co-delivery of minicircle DNA and anti-tumoral drugs.
    Gaspar VM; Moreira AF; Costa EC; Queiroz JA; Sousa F; Pichon C; Correia IJ
    Colloids Surf B Biointerfaces; 2015 Oct; 134():287-94. PubMed ID: 26209779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 3-D tumor spheroids by timed-released hydrophilic and hydrophobic drugs from multilayered polymeric microparticles.
    Lee WL; Guo WM; Ho VH; Saha A; Chong HC; Tan NS; Widjaja E; Tan EY; Loo SC
    Small; 2014 Oct; 10(19):3986-96. PubMed ID: 24947558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of novel PBAE/PLGA polymer blend microparticles for DNA vaccine delivery.
    Balashanmugam MV; Nagarethinam S; Jagani H; Josyula VR; Alrohaimi A; Udupa N
    ScientificWorldJournal; 2014; 2014():385135. PubMed ID: 25401137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability.
    Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO
    Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.